AME vs FHTX · P/E 30, rev $2.04B vs rev $19.3M
Ametek Inc (AME) versus Foghorn Therapeutics Inc (FHTX) — a side-by-side from cached financials, not a winner call.
Ametek Inc (AME) is a specialty industrial machinery company listed on US.
Foghorn Therapeutics Inc (FHTX) is a biotechnology company listed on NASDAQ.
Latest reported AME revenue for 2026-06-30 was $2.04B. Net income was $406.9M. Revenue was up 6.0% from 2026-03-31 to 2026-06-30. AME currently screens at market cap $42.11B and trailing P/E 29.9.
Latest reported FHTX revenue for 2026-06-30 was $19.3M. Net income was -$27.1M. FHTX currently screens at market cap $237.8M.
AME currently screens at market cap $42.11B and trailing P/E 29.9. FHTX currently screens at market cap $237.8M.
Not investment advice. Open the AME and FHTX stock pages for the full models.
Not investment advice.